Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate

被引:169
|
作者
van Meeteren, LA
Ruurs, P
Christodoulou, E
Goding, JW
Takakusa, H
Kikuchi, K
Perrakis, A
Nagano, T
Moolenaar, WH
机构
[1] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
[3] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands
[4] Monash Univ, Sch Med, Dept Pathol & Immunol, Melbourne, Vic 3181, Australia
[5] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan
关键词
D O I
10.1074/jbc.M413183200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autotaxin (ATX) or nucleotide pyrophosphatase/ phosphodiesterase 2 (NPP2) is an NPP family member that promotes tumor cell motility, experimental metastasis, and angiogenesis. ATX primarily functions as a lysophospholipase D, generating the lipid mediator lysophosphatidic acid (LPA) from lysophosphatidylcholine. ATX uses a single catalytic site for the hydrolysis of both lipid and non-lipid phosphodiesters, but its regulation is not well understood. Using a new fluorescence resonance energy transfer-based phosphodiesterase sensor that reports ATX activity with high sensitivity, we show here that ATX is potently and specifically inhibited by LPA and sphingosine 1-phosphate (S1P) in a mixed-type manner (K-i similar to 10(-7) M). The homologous ecto-phosphodiesterase NPP1, which lacks lysophospholipase D activity, is insensitive to LPA and S1P. Our results suggest that, by repressing ATX activity, LPA can regulate its own biosynthesis in the extracellular environment, and they reveal a novel role for S1P as an inhibitor of ATX, in addition to its well established role as a receptor ligand.
引用
收藏
页码:21155 / 21161
页数:7
相关论文
共 50 条
  • [41] Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate
    An, SZ
    Goetz, EJ
    Lee, HY
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1998, : 147 - 157
  • [42] Synthesis of fluorescence-labeled sphingosine and sphingosine 1-phosphate; Effective tools for sphingosine and sphingosine 1-phosphate behavior
    Hakogi, T
    Shigenari, T
    Katsumura, S
    Sano, T
    Kohno, T
    Igarashi, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 661 - 664
  • [43] Activation of protein-tyrosine kinase Syk in human platelets stimulated with lysophosphatidic acid or sphingosine 1-phosphate
    Yang, LB
    Yatomi, Y
    Hisano, N
    Qi, RM
    Asazuma, N
    Satoh, K
    Igarashi, Y
    Ozaki, Y
    Kume, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (02) : 440 - 444
  • [44] Sphingosine kinase and sphingosine 1-phosphate in asthma
    Lai, Wen-Qi
    Wong, W. S. Fred
    Leung, Bernard P.
    BIOSCIENCE REPORTS, 2011, 31 (02) : 145 - 150
  • [45] Sphingosine 1-phosphate receptors
    Hla, T
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 64 (1-4): : 135 - 142
  • [46] Sphingosine 1-Phosphate and Atherosclerosis
    Kurano, Makoto
    Yatomi, Yutaka
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (01) : 16 - 26
  • [47] Sphingosine 1-phosphate signalling
    Mendelson, Karen
    Evans, Todd
    Hla, Timothy
    DEVELOPMENT, 2014, 141 (01): : 5 - 9
  • [48] Sphingosine 1-phosphate and inflammation
    Obinata, Hideru
    Hla, Timothy
    INTERNATIONAL IMMUNOLOGY, 2019, 31 (09) : 617 - 625
  • [49] Sphingosine 1-phosphate and cancer
    Nigel J. Pyne
    Susan Pyne
    Nature Reviews Cancer, 2010, 10 : 489 - 503
  • [50] Sphingosine 1-phosphate and cancer
    Pyne, Nigel J.
    Pyne, Susan
    NATURE REVIEWS CANCER, 2010, 10 (07) : 489 - 503